Toggle navigation
Home
Search
Services
Blog
Contact
About
Nucleotide Dimers as Anti-HIV Agents
Hahn, Elliot F.
Baker Norton Pharmaceuticals, Inc., Miami, FL, United States
Search 7 grants from Elliot Hahn
Search grants from Baker Norton Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Investigating the role of microRNAs in microglia in a mouse model of Alzheimer?s Disease
Visual Control of Adaptive Behavior - Locomotion
Oral Versus Depot Naltrexone for Relapse Prevention
Molecular Genetics of Human Ribosomal Proteins
Geriatric Medicine Academic Award
Recently added grants:
Risk Stratification and Decision Support to Improve Care and Outcomes in Children with Pneumonia
Role of Microbiome in Neonatal Lung Maturation and Immune Susceptibility
Mentoring in patient-oriented research on HIV and global health
The Role of Canonical and Non-canonical Autophagy in B Cell Immunity
The Gonorrhea Vaccine Cooperative Research Center
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44AI028124-03
Application #
2064264
Study Section
Physiological Sciences Study Section (PSF)
Project Start
1989-06-01
Project End
1992-08-31
Budget Start
1991-09-01
Budget End
1992-08-31
Support Year
3
Fiscal Year
1991
Total Cost
Indirect Cost
Institution
Name
Baker Norton Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Miami
State
FL
Country
United States
Zip Code
33178
Related projects
NIH 1991
R44 AI
Nucleotide Dimers as Anti-HIV Agents
Hahn, Elliot F. / Baker Norton Pharmaceuticals, Inc.
NIH 1990
R44 AI
Nucleotide Dimers as Anti-HIV Agents
Hahn, Elliot F. / Baker Norton Pharmaceuticals, Inc.
Comments
Be the first to comment on Elliot Hahn's grant